Andlauer Healthcare Group Inc. (TSX:AND)
Canada · Delayed Price · Currency is CAD 54.97
+0.01 (0.02%)
Inactive · Last trade price on Nov 4, 2025
Andlauer Healthcare Group Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 650.58 | 650.48 | 647.95 | 648.42 | 440.12 | 314.34 | |
Revenue Growth | 0.34% | 0.39% | -0.07% | 47.33% | 40.01% | 8.40% |
Cost of Revenue | 430.39 | 432.34 | 432.32 | 425.12 | 287.85 | 209.13 |
Gross Profit | 220.2 | 218.14 | 215.63 | 223.3 | 152.26 | 105.21 |
Selling, General & Admin | 58.29 | 53.24 | 51.43 | 48.16 | 35.24 | 28.55 |
Operating Expenses | 129.21 | 124.18 | 119.58 | 112.61 | 77.96 | 56.57 |
Operating Income | 90.99 | 93.96 | 96.05 | 110.69 | 74.3 | 48.64 |
Interest Expense | -8.26 | -7.59 | -8.21 | -6.86 | -6.22 | -4.6 |
Interest & Investment Income | 1.38 | 2.15 | 3.17 | 0.6 | 0.2 | 0.29 |
Earnings From Equity Investments | 0.8 | - | - | - | 2.47 | - |
Other Non Operating Income (Expenses) | 0.16 | -0.33 | -0.41 | -0.33 | 0.23 | -0.05 |
EBT Excluding Unusual Items | 85.07 | 88.2 | 90.61 | 104.1 | 70.98 | 44.28 |
Merger & Restructuring Charges | - | - | - | -0.35 | -1.81 | -0.07 |
Gain (Loss) on Sale of Investments | - | - | - | - | 37.92 | - |
Gain (Loss) on Sale of Assets | 5.15 | - | - | - | - | - |
Asset Writedown | - | - | - | - | 0.14 | - |
Other Unusual Items | - | - | - | - | 1.21 | 2.37 |
Pretax Income | 90.21 | 88.2 | 90.61 | 103.76 | 108.44 | 46.58 |
Income Tax Expense | 22.72 | 23.73 | 24.47 | 27.48 | 18.49 | 8.87 |
Earnings From Continuing Operations | 67.49 | 64.47 | 66.14 | 76.28 | 89.95 | 37.71 |
Net Income | 67.49 | 64.47 | 66.14 | 76.28 | 89.95 | 37.71 |
Net Income to Common | 67.49 | 64.47 | 66.14 | 76.28 | 89.95 | 37.71 |
Net Income Growth | 4.55% | -2.53% | -13.29% | -15.21% | 138.52% | 26.67% |
Shares Outstanding (Basic) | 39 | 40 | 42 | 42 | 39 | 38 |
Shares Outstanding (Diluted) | 40 | 41 | 43 | 43 | 40 | 38 |
Shares Change | -5.50% | -3.90% | -0.30% | 6.70% | 3.94% | 1.87% |
EPS (Basic) | 1.72 | 1.60 | 1.58 | 1.82 | 2.30 | 1.00 |
EPS (Diluted) | 1.70 | 1.58 | 1.55 | 1.79 | 2.25 | 0.98 |
EPS Growth | 12.02% | 1.93% | -13.41% | -20.44% | 129.59% | 24.05% |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | 102.7 | 106.84 | 80.9 | 111.38 | 76.07 | 46.04 |
Free Cash Flow Per Share | 2.58 | 2.61 | 1.90 | 2.61 | 1.90 | 1.20 |
Dividend Per Share | 0.460 | 0.420 | 0.340 | 0.260 | 0.200 | 0.199 |
Dividend Growth | 21.05% | 23.53% | 30.77% | 30.00% | 0.27% | 1648.12% |
Gross Margin | 33.85% | 33.53% | 33.28% | 34.44% | 34.60% | 33.47% |
Operating Margin | 13.99% | 14.45% | 14.82% | 17.07% | 16.88% | 15.47% |
Profit Margin | 10.37% | 9.91% | 10.21% | 11.76% | 20.44% | 12.00% |
Free Cash Flow Margin | 15.79% | 16.43% | 12.48% | 17.18% | 17.28% | 14.65% |
EBITDA | 104.26 | 131.39 | 133.75 | 145.65 | 90.38 | 53.61 |
EBITDA Margin | 16.03% | 20.20% | 20.64% | 22.46% | 20.54% | 17.05% |
D&A For EBITDA | 13.27 | 37.43 | 37.7 | 34.96 | 16.08 | 4.97 |
EBIT | 90.99 | 93.96 | 96.05 | 110.69 | 74.3 | 48.64 |
EBIT Margin | 13.99% | 14.45% | 14.82% | 17.07% | 16.88% | 15.47% |
Effective Tax Rate | 25.19% | 26.91% | 27.00% | 26.49% | 17.05% | 19.03% |